tiprankstipranks
Trending News
More News >
US Stem Cell Inc (DE:BHV)
BERLIN:BHV

US Stem Cell (BHV) Revenue

Compare
0 Followers

US Stem Cell Revenue

US Stem Cell had a revenue of 0.00 in the quarter ending Sep 30, 2023, with ―. This bring the company's revenue in the last twelve months to 19.97K, Increased -41.63%. In the fiscal year ending Dec 31, 2022, US Stem Cell had annual revenue of 82.05K with -59.13% growth.
Revenue (ttm)
19.97K
Revenue Growth
P/S Ratio
0.69
Revenue/Employee
$7,459
Employees
11
Market Cap
$56.58K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2022
82.05K-118.70K-59.13%
Dec 31, 2021
200.75K-76.34K-27.55%
Dec 31, 2020
277.09K-2.80M-90.98%
Dec 31, 2019
3.07M-3.63M-54.15%
Dec 31, 2018
6.70M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis